This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials

The final analyses for this trial were published on 11 March – please see the full release  Novavax UK and SA Final Data Announcement March 11 2021 FINAL[87]

Corporate COVID 19 Healthcare Innovation Partnerships Research